文献速递关节外科

术前使用选择性5-羟色胺再摄取抑制剂与全髋关节置换术后并发症风险增加相关:剂量反应分析

Preoperative Selective Serotonin Reuptake Inhibitor Use is Associated With Increased Complication Risk After Total Hip Arthroplasty: A Dose-Response Analysis.
PubMed 文献 · J Arthroplasty · 2026-10-16

基于2010至2023年理赔数据库,77,958例术前60天内配取SSRI的原发性全髋关节置换患者按1:3匹配233,277例对照。术前SSRI使用与2年并发症率更高相关(5.2% vs 3.2%,P<0.001),假体周围感染、脱位、骨折、松动及翻修风险均增加,但未观察到剂量依赖性关系。

要点

  • 术前SSRI使用与THA术后2年并发症率升高相关(5.2% vs 3.2%,P<0.001)。
  • SSRI使用增加假体松动(OR 1.5)、假体周围骨折(OR 1.8)、假体周围感染(OR 1.7)、脱位(OR 2.0)和翻修(OR 1.7)风险(均P<0.001)。
  • 未发现剂量依赖性关系,提示SSRI可能不直接导致这些并发症。

核心结论

  • 术前SSRI使用无论剂量高低均与THA术后2年假体周围感染、脱位、骨折、松动和翻修率升高相关。
  • 无剂量反应关系提示SSRI不太可能直接导致这些并发症。

研究设计与样本

  • 基于理赔数据库(2010至2023年)的回顾性队列研究。
  • 纳入77,958例无骨质疏松且术前60天内配取SSRI的原发性THA患者,按1:3匹配233,277例SSRI未使用者,匹配因素包括年龄、性别、Charlson合并症指数及认知障碍、抑郁、焦虑和物质使用史。
  • SSRI剂量按数量、疗程和强度标准化后分为低剂量(0至30 mg)、中剂量(30至100 mg)和高剂量(大于100 mg)。
  • 采用多变量回归和Kaplan-Meier分析评估2年随访的手术并发症和无翻修生存率。

主要发现

  • SSRI使用者2年并发症率为5.2%,对照组为3.2%(P<0.001)。
  • 调整多变量分析显示SSRI使用与假体松动(OR 1.5)、假体周围骨折(OR 1.8)、假体周围感染(OR 1.7)、脱位(OR 2.0)和翻修手术(OR 1.7)风险增加相关(均P<0.001)。
  • 未观察到剂量依赖性关系;高剂量SSRI时假体松动接近统计学显著性(OR 3.7,P=0.07)。
  • Kaplan-Meier分析显示SSRI使用者2年无翻修生存率降低(P<0.001)。

关键数值与推荐

  • SSRI使用者2年并发症率5.2% vs 对照组3.2%(P<0.001)。
  • 假体松动OR 1.5,假体周围骨折OR 1.8,假体周围感染OR 1.7,脱位OR 2.0,翻修OR 1.7(均P<0.001)。
  • 高剂量SSRI时假体松动OR 3.7(P=0.07)。

临床怎么用

  • 术前应识别SSRI使用患者并告知其THA术后并发症风险可能升高。
  • SSRI使用患者术后2年内需加强随访监测假体周围感染、脱位、骨折、松动和翻修。
  • 剂量高低不改变风险提示,不应仅因剂量调整而改变围手术期管理决策。

局限性

  • 回顾性理赔数据库研究可能存在编码偏倚和未测量混杂因素。
  • 无剂量反应关系提示可能存在残余混杂,SSRI使用可能仅是风险标志而非直接原因。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Preoperative selective serotonin reuptake inhibitor (SSRI) use has been associated with adverse outcomes following primary total hip arthroplasty (THA). This study examined whether complication rates vary based on SSRI daily dosage. METHODS: A claims database (2010 to 2023) identified 77,958 primary THA patients who did not have osteoporosis and who filled an SSRI prescription 60 days preoperatively. Patients were matched 1:3 to SSRI-naive individuals by age, sex, Charlson Comorbidity Index, and history of cognitive disorders, depression, anxiety, and substance use. Overall, 77,958 SSRI users were matched to 233,277 controls (mean age 65 years). After matching, baseline demographics and rates of anxiety and depression (all P > 0.13) were similar between cohorts. The SSRI doses were standardized using quantity, duration, and strength, then stratified as low (0 to 30 mg), medium (30 to 100 mg), or high (greater than 100 mg). Multivariate regression and Kaplan-Meier analysis assessed surgical complications and revision-free survival at 2-year follow-up. RESULTS: Preoperative SSRI use was associated with greater 2-year complications (5.2 versus 3.2%, P < 0.001). In adjusted multivariate analysis, SSRI use was associated with increased odds of component loosening (OR [odds ratio] 1.5), periprosthetic fracture (OR 1.8), periprosthetic joint infection (OR 1.7), dislocation (OR 2.0), and revision surgery (OR 1.7) (all P < 0.001). There was no dose-dependent relationship observed. Component loosening approached statistical significance at high SSRI doses (OR 3.7, P = 0.07). Kaplan-Meier analysis demonstrated reduced revision-free survival among SSRI users (P < 0.001) at 2-year follow-up. CONCLUSION: Preoperative SSRI use, regardless of dose, was associated with higher 2-year rates of periprosthetic joint infection, dislocation, fracture, loosening, and revision. However, the absence of a dose-response relationship suggests that SSRIs are unlikely to be directly responsible for these complications.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Alfonsi SP, Zickler CL, Yadav AS, et al. Preoperative Selective Serotonin Reuptake Inhibitor Use is Associated With Increased Complication Risk After Total Hip Arthroplasty: A Dose-Response Analysis. J Arthroplasty. 2026. PMID: 42887707. doi:10.1016/j.arth.2026.10.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。